{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Acridine-chromenone", "Alzheimer\u2019s disease", "Anti-cholinesterase", "Docking study", "Neuroprotective activity", "Quinoline-chromenone", "\u03b2-Secretase inhibitor"]], "OtherID": [], "CitationSubset": ["IM"], "InvestigatorList": [], "SpaceFlightMission": [], "GeneralNote": [], "OtherAbstract": [], "PMID": "27289559", "DateCompleted": {"Year": "2017", "Month": "06", "Day": "02"}, "DateRevised": {"Year": "2017", "Month": "12", "Day": "14"}, "Article": {"ArticleDate": [{"Year": "2016", "Month": "06", "Day": "02"}], "ELocationID": ["10.1016/j.bioorg.2016.06.001", "S0045-2068(16)30055-4"], "Language": ["eng"], "Journal": {"ISSN": "1090-2120", "JournalIssue": {"Volume": "67", "PubDate": {"Year": "2016", "Month": "Aug"}}, "Title": "Bioorganic chemistry", "ISOAbbreviation": "Bioorg Chem"}, "ArticleTitle": "Design and synthesis of novel anti-Alzheimer's agents: Acridine-chromenone and quinoline-chromenone hybrids.", "Pagination": {"StartPage": "84", "EndPage": "94", "MedlinePgn": "84-94"}, "Abstract": {"AbstractText": ["A novel series of acridine-chromenone and quinoline-chromenone hybrids were designed, synthesized, and evaluated as anti-Alzheimer's agents. All synthesized compounds were evaluated as cholinesterases (ChEs) inhibitors and among them, 7-(4-(6-chloro-2,3-dihydro-1H-cyclopenta[b]quinolin-9-ylamino)phenoxy)-4-methyl-2H-chromen-2-one (8e) exhibited the most potent anti-acetylcholinesterase (AChE) inhibitory activity (IC50=16.17\u03bcM) comparing with rivastigmine (IC50=11.07\u03bcM) as the reference drug. Also, compound 8e was assessed for its \u03b2-secretase (BACE1) inhibitory and neuroprotective activities which demonstrated satisfactory results. It should be noted that both kinetic study on the inhibition of AChE and molecular modeling revealed that compound 8e interacted simultaneously with both the catalytic active site (CAS) and peripheral anionic site (PAS) of AChE."], "CopyrightInformation": "Copyright \u00a9 2016 Elsevier Inc. All rights reserved."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicinal Chemistry, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran."}], "LastName": "Najafi", "ForeName": "Zahra", "Initials": "Z"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal Plants Research Center, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran; Persian Medicine and Pharmacy Research Center, Tehran University of Medical Sciences, Tehran, Iran."}], "LastName": "Saeedi", "ForeName": "Mina", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Drug Design and Development Research Center, Tehran University of Medical Sciences, Tehran, Iran."}], "LastName": "Mahdavi", "ForeName": "Mohammad", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Persian Medicine and Pharmacy Research Center, Tehran University of Medical Sciences, Tehran, Iran."}], "LastName": "Sabourian", "ForeName": "Reyhaneh", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran."}], "LastName": "Khanavi", "ForeName": "Mahnaz", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicinal Chemistry, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran."}], "LastName": "Tehrani", "ForeName": "Maliheh Barazandeh", "Initials": "MB"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Cellular Biotechnology at Cell Science Research Center, Royan Institute for Biotechnology, ACECR, Isfahan, Iran."}], "LastName": "Moghadam", "ForeName": "Farshad Homayouni", "Initials": "FH"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal and Natural Products Chemistry Research Center, Shiraz University of Medical Sciences, Shiraz, Iran."}], "LastName": "Edraki", "ForeName": "Najmeh", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Persian Medicine and Pharmacy Research Center, Tehran University of Medical Sciences, Tehran, Iran."}], "LastName": "Karimpor-Razkenari", "ForeName": "Elahe", "Initials": "E"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology and Toxicology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran."}], "LastName": "Sharifzadeh", "ForeName": "Mohammad", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicinal Chemistry, Faculty of Pharmacy and Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences, Tehran, Iran."}], "LastName": "Foroumadi", "ForeName": "Alireza", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicinal Chemistry, Faculty of Pharmacy and Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences, Tehran, Iran."}], "LastName": "Shafiee", "ForeName": "Abbas", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicinal Chemistry, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran; Persian Medicine and Pharmacy Research Center, Tehran University of Medical Sciences, Tehran, Iran. Electronic address: akbarzad@tums.ac.ir."}], "LastName": "Akbarzadeh", "ForeName": "Tahmineh", "Initials": "T"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Bioorg Chem", "NlmUniqueID": "1303703", "ISSNLinking": "0045-2068"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Acridines"}, {"RegistryNumber": "0", "NameOfSubstance": "Cholinesterase Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "Chromones"}, {"RegistryNumber": "0", "NameOfSubstance": "Neuroprotective Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Quinolines"}, {"RegistryNumber": "E66400VT9R", "NameOfSubstance": "quinoline"}, {"RegistryNumber": "EC 3.1.1.8", "NameOfSubstance": "Cholinesterases"}], "MeshHeadingList": [{"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Acridines"}, {"QualifierName": ["drug therapy", "metabolism"], "DescriptorName": "Alzheimer Disease"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["chemical synthesis", "chemistry", "pharmacology"], "DescriptorName": "Cholinesterase Inhibitors"}, {"QualifierName": ["metabolism"], "DescriptorName": "Cholinesterases"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Chromones"}, {"QualifierName": [], "DescriptorName": "Dose-Response Relationship, Drug"}, {"QualifierName": [], "DescriptorName": "Drug Design"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Models, Molecular"}, {"QualifierName": [], "DescriptorName": "Molecular Structure"}, {"QualifierName": ["chemical synthesis", "chemistry", "pharmacology"], "DescriptorName": "Neuroprotective Agents"}, {"QualifierName": [], "DescriptorName": "PC12 Cells"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Quinolines"}, {"QualifierName": [], "DescriptorName": "Rats"}, {"QualifierName": [], "DescriptorName": "Structure-Activity Relationship"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2016", "Month": "2", "Day": "24"}, {"Year": "2016", "Month": "5", "Day": "31"}, {"Year": "2016", "Month": "6", "Day": "1"}, {"Year": "2016", "Month": "6", "Day": "13", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "6", "Day": "13", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "6", "Day": "3", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["27289559", "10.1016/j.bioorg.2016.06.001", "S0045-2068(16)30055-4"]}}], "PubmedBookArticle": []}